International consensus on (ICON) pediatric asthma
暂无分享,去创建一个
H. Zar | G. Wennergren | T. Casale | R. Lockey | J. Lötvall | K. Carlsen | O. Kalayci | N. Papadopoulos | R. Pawankar | E. Valovirta | N. Aït-Khaled | Y. Chen | A. Custovic | P. Kuna | D. Price | M. Mäkelä | C. Akdis | G. Roberts | S. Lau | P. Sly | L. Bacharier | G. Wong | J. C. Jongste | J. Castro‐Rodriguez | P. Heymann | J. Gern | E. Baraldi | S. Stick | S. Szefler | D. Goh | R. Stein | R. Lemanske | R. Zeiger | N. Rosário | J. Wildhaber | M. Everard | D. Ledford | T. Guilbert | L. Taussig | C. Robertson | G. Hedlin | D. Jackson | P. Pohunek | H. Arakawa | D. Wallace | P. Souef | A. Custovic | O. Kalayci | P. Kuna | D. Price | E. Valovirta | H. Paramesh | E. Weinberg | A. Liu | H. P. Bever | J. Blic | A. Boner | W. Burks | Y. El-Gamal | T. Frischer | M. Geller | J. Gereda | S. Hong | E. Hossny | J. L. Huang | S. Kling | S. I. Lee | K. Lodrup-Carlsen | A. Morikawa | A. Nieto | J. Pongracic | L. J. Rossenwasser | P. Vichyanond | G. Hedlin | K.‐H. Carlsen | R. Pawankar | J. Lötvall | C. A. Akdis | Y. Z. Chen | S. Lau | N. Rosario | P. Vichyanond | G. Roberts | N. G. Papadopoulos | H. Arakawa | J. Gern | R. Lemanske | P. Souef | M. Mäkelä | G. Wong | H. Zar | L. B. Bacharier | E. Baraldi | H. P. Bever | J. Blic | A. Boner | W. Burks | T. B. Casale | J. A. Castro‐Rodriguez | Y. M. El‐Gamal | M. L. Everard | T. Frischer | M. Geller | J. Gereda | D. Y. Goh | T. W. Guilbert | P. W. Heymann | S. J. Hong | E. M. Hossny | J. L. Huang | D. J. Jackson | J. C. Jongste | N. Aït‐Khaled | S. Kling | D. K. Ledford | S. I. Lee | A. H. Liu | R. F. Lockey | K. Lødrup‐Carlsen | A. Morikawa | A. Nieto | H. Paramesh | P. Pohunek | J. Pongracic | C. Robertson | L. J. Rossenwasser | P. D. Sly | R. Stein | S. Stick | S. Szefler | L. M. Taussig | D. Wallace | E. Weinberg | G. Wennergren | J. Wildhaber | R. S. Zeiger | N. Aït-Khaled | S. Lee
[1] A. Woodcock,et al. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years. , 2004, American journal of respiratory and critical care medicine.
[2] S. Szefler,et al. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. , 2003, Chest.
[3] A. Bush,et al. Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. , 2012, The Journal of allergy and clinical immunology.
[4] E. Valovirta,et al. The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school , 2010, Allergy.
[5] N. York,et al. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six‐year follow‐up study. , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[6] M. Inman,et al. Effect of asthma treatment on fitness, daily activity and body composition in children with asthma , 2010, Allergy.
[7] A. Edwards,et al. The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma. , 1993, The European respiratory journal.
[8] H. Bisgaard,et al. Safety and tolerability of montelukast in placebo‐controlled pediatric studies and their open‐label extensions , 2009, Pediatric pulmonology.
[9] S. Walker,et al. Anti-IgE for chronic asthma in adults and children. , 2006, The Cochrane database of systematic reviews.
[10] T. Lasserson,et al. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. , 2006, The Cochrane database of systematic reviews.
[11] S. Holgate. Epithelium dysfunction in asthma. , 2007, The Journal of allergy and clinical immunology.
[12] Daily exhaled nitric oxide measurements and asthma exacerbations in children , 2012, Allergy.
[13] Phil A. Silva,et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. , 2003, The New England journal of medicine.
[14] F. Ram,et al. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. , 2005, The Cochrane database of systematic reviews.
[15] P. Ind,et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid , 1994, The Lancet.
[16] A. Woolcock,et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. , 1996, American journal of respiratory and critical care medicine.
[17] M. Pitt,et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. , 2008, Health technology assessment.
[18] Daniel J Jackson,et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. , 2010, The New England journal of medicine.
[19] J. Castro‐Rodriguez,et al. Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review. , 2011, Chest.
[20] C. Baena-Cagnani,et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. , 2008, Chest.
[21] Carlos E. Rodriguez-Martinez,et al. Discriminative properties of two predictive indices for asthma diagnosis in a sample of preschoolers with recurrent wheezing , 2011, Pediatric pulmonology.
[22] C. Sorkness,et al. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. , 2004, American journal of respiratory and critical care medicine.
[23] A R Jadad,et al. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation , 2000, BMJ : British Medical Journal.
[24] M. Chan-yeung,et al. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. , 2005, The Journal of allergy and clinical immunology.
[25] James Tonascia,et al. Predictors of remitting, periodic, and persistent childhood asthma. , 2010, The Journal of allergy and clinical immunology.
[26] Alfred O. Berg,et al. Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .
[27] S. Johnston,et al. Asthma exacerbations: Origin, effect, and prevention , 2011, Journal of Allergy and Clinical Immunology.
[28] J. Castro‐Rodriguez,et al. beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. , 2004, The Journal of pediatrics.
[29] M. Kopp,et al. Role of immunmodulators in allergen‐specific immunotherapy , 2011, Allergy.
[30] J. Bousquet,et al. Tissue remodelling in upper airways: where is the link with lower airway remodelling? , 2006, Allergy.
[31] D. Robinson. The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle? , 2004, The Journal of allergy and clinical immunology.
[32] T. Lasserson,et al. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. , 2010, The Cochrane database of systematic reviews.
[33] M. Wickman,et al. Development and comorbidity of eczema, asthma and rhinitis to age 12 – data from the BAMSE birth cohort , 2012, Allergy.
[34] Fernando Maria Benedictis,et al. Use of Inhaler Devices in Pediatric Asthma , 2003, Paediatric drugs.
[35] F. Martinez. New insights into the natural history of asthma: primary prevention on the horizon. , 2011, The Journal of allergy and clinical immunology.
[36] R. Platt,et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. , 2009, The New England journal of medicine.
[37] S. Pedersen,et al. Preschool asthma--not so easy to diagnose. , 2007, Primary care respiratory journal : journal of the General Practice Airways Group.
[38] G. Joos. The role of neuroeffector mechanisms in the pathogenesis of asthma , 2001, Current allergy and asthma reports.
[39] M. Strippoli,et al. Meta‐analysis of mould and dampness exposure on asthma and allergy in eight European birth cohorts: an ENRIECO initiative , 2011, Allergy.
[40] M. Korppi,et al. Adulthood asthma after wheezing in infancy: a questionnaire study at 27 years of age , 2010, Allergy.
[41] Mark S Levenson,et al. Age and Risks of FDA-Approved Long-Acting β2-Adrenergic Receptor Agonists , 2011, Pediatrics.
[42] N. Papadopoulos,et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report , 2007, Allergy.
[43] British guideline on the management of asthma. , 2003, Thorax.
[44] M. Krawiec,et al. Leukotriene receptor antagonists. , 2002, Seminars in respiratory and critical care medicine.
[45] J. Martin,et al. Basic mechanisms of development of airway structural changes in asthma , 2006, European Respiratory Journal.
[46] P. Eng,et al. Long‐term efficacy of preseasonal grass pollen immunotherapy in children , 2002, Allergy.
[47] B. Niggemann,et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study , 2006, The Lancet.
[48] P. Brand. The Asthma Predictive Index: not a useful tool in clinical practice. , 2011, The Journal of allergy and clinical immunology.
[49] P. Paré,et al. A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation. , 2000, Canadian respiratory journal.
[50] C E Reed,et al. A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. , 1992, The American review of respiratory disease.
[51] Amanda J Lee,et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. , 2007, American journal of respiratory and critical care medicine.
[52] J Bousquet,et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.
[53] W. Hop,et al. Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial , 2007, European Respiratory Journal.
[54] P. Barnes,et al. Inhaled glucocorticoids for asthma. , 1995, The New England journal of medicine.
[55] P. Dorinsky,et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. , 2006, Chest.
[56] G H Guyatt,et al. Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.
[57] W. Busse,et al. The US Food and Drug Administration and long-acting beta2-agonists: the importance of striking the right balance between risks and benefits of therapy? , 2010, The Journal of allergy and clinical immunology.
[58] D. Cockcroft,et al. Direct and indirect challenges in the clinical assessment of asthma. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[59] J. Cowan,et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.
[60] L. Edwards,et al. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial. , 2001, The Journal of allergy and clinical immunology.
[61] S. Durham,et al. Allergen immunotherapy: does it work and, if so, how and for how long? , 2000, Thorax.
[62] J. Wildhaber,et al. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. , 1999, The European respiratory journal.
[63] J. Castro‐Rodriguez,et al. Safety of long-acting β agonists for the treatment of asthma: clearing the air , 2011, Thorax.
[64] S. Szefler,et al. Alternative agents for anti-inflammatory treatment of asthma. , 1998, The Journal of allergy and clinical immunology.
[65] Philip Marcus,et al. Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.
[66] Margaret W Leigh,et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. , 2011, American journal of respiratory and critical care medicine.
[67] K. Chung,et al. Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation? , 2000, The European respiratory journal.
[68] M. Weatherall,et al. Systematic review of the dose-response relation of inhaled fluticasone propionate , 2004, Archives of Disease in Childhood.
[69] E. Israel,et al. Treatment of asthma with drugs modifying the leukotriene pathway. , 1999, The New England journal of medicine.
[70] I. Pavord,et al. A new perspective on concepts of asthma severity and control , 2008, European Respiratory Journal.
[71] J. Stockman. Results of a Home-Based Environmental Intervention Among Urban Children With Asthma , 2006 .
[72] B. Rowe,et al. Cochrane review: Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma , 2006 .
[73] T. Casale,et al. We Call for iCAALL: International Collaboration in Asthma, Allergy and Immunology , 2012, The World Allergy Organization journal.
[74] Third Expert Panel on theDiagnosis,et al. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .
[75] J. Mitchell,et al. Do we always need computed tomography to detect and treat parapneumonic pleural effusion? , 2012, European Respiratory Journal.
[76] H. Bisgaard,et al. Plethysmographic measurements of specific airway resistance in young children. , 2005, Chest.
[77] U. Wahn,et al. Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC Study , 2005, Pediatrics.
[78] A. Sheikh,et al. EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy , 2012, Clinical and Translational Allergy.
[79] N. Pearce,et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC) , 2007, Thorax.
[80] T. Aitchison,et al. Compliance with inhaled asthma medication in preschool children. , 1995, Thorax.
[81] M. Kosinski,et al. Test for respiratory and asthma control in kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. , 2009, The Journal of allergy and clinical immunology.
[82] H. Bisgaard,et al. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. , 2006, Chest.
[83] R. Lipchik. Addition of salmeterol to usual asthma pharmacotherapy may increase respiratory related deaths or life threatening experiences , 2006, Evidence-based medicine.
[84] M. Sears. Safety of long-acting beta-agonists: are new data really required? , 2009, Chest.
[85] K. L. Lødrup Carlsen,et al. Asthma prediction in school children; the value of combined IgE‐antibodies and obstructive airways disease severity score * , 2010, Allergy.
[86] J. Castro‐Rodriguez,et al. Olive oil during pregnancy is associated with reduced wheezing during the first year of life of the offspring , 2010, Pediatric pulmonology.
[87] J. L. Rau,et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. , 2005, Chest.
[88] Peter D Sly,et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger , 2011, Pediatric pulmonology.
[89] H. Windom,et al. Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. , 2003, The Journal of allergy and clinical immunology.
[90] R. Pauwels,et al. GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .
[91] C. Bierman. Theophylline in asthma , 1976, Drug and therapeutics bulletin.
[92] N Franklin Adkinson,et al. Long-term effects of budesonide or nedocromil in children with asthma. , 2000, The New England journal of medicine.
[93] Urs Frey,et al. Forced oscillation technique in infants and young children. , 2005, Paediatric respiratory reviews.
[94] Dharmendra.,et al. Allergy , 1937, The Lancet.
[95] A. Boner,et al. Asthma, allergy and respiratory infections: the vitamin D hypothesis , 2012, Allergy.
[96] Urs Frey,et al. Validation of the Asthma Predictive Index and comparison with simpler clinical prediction rules. , 2011, The Journal of allergy and clinical immunology.
[97] H. Bisgaard,et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. , 2006, The New England journal of medicine.
[98] T. Lasserson,et al. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. , 2010, The Cochrane database of systematic reviews.
[99] F. Ducharme,et al. Inhaled steroids for episodic viral wheeze of childhood. , 2000, The Cochrane database of systematic reviews.
[100] Dose Response of Inhaled Corticosteroids in Children With Persistent Asthma: A Systematic Review , 2011, Pediatrics.
[101] G. Heldt,et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. , 2005, The Journal of allergy and clinical immunology.
[102] Á. Cruz,et al. Reduction of asthma burden is possible through National Asthma Plans , 2010, Allergy.
[103] G. Crompton,et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. , 2001, The European respiratory journal.
[104] L. Edwards,et al. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma. , 2000, The Journal of allergy and clinical immunology.
[105] J Bousquet,et al. A pediatric asthma management program in a low‐income setting resulting in reduced use of health service for acute asthma , 2010, Allergy.
[106] S. Holgate,et al. The mechanisms, diagnosis, and management of severe asthma in adults , 2006, The Lancet.
[107] A. Stipić-Marković,et al. Viruses and bacteria in acute asthma exacerbations – A GA2LEN‐DARE* systematic review , 2010, Allergy.
[108] R. Cohn,et al. Results of a physician and respiratory therapist collaborative effort to improve long-term metered-dose inhaler technique in a pediatric asthma clinic. , 2004, Respiratory care.
[109] T. Haahtela,et al. Lung function, airway remodelling and inflammation in symptomatic infants: outcome at 3 years , 2011, Thorax.
[110] M. Plebani,et al. Markers of eosinophilic and neutrophilic inflammation in bronchoalveolar lavage of asthmatic and atopic children , 2009, Allergy.
[111] W. Morgan,et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.
[112] J. Weiler,et al. Exercise‐induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy) , 2008, Allergy.
[113] Qutayba Hamid,et al. Immunobiology of asthma. , 2009, Annual review of physiology.
[114] Bradley E. Chipps. Use of Exhaled Nitric Oxide Measurements to Guide Treatment in Chronic Asthma , 2006, Pediatrics.
[115] K. Bønnelykke,et al. Long-term studies of the natural history of asthma in childhood. , 2010, The Journal of allergy and clinical immunology.
[116] S. Lau,et al. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. , 1997, The Journal of allergy and clinical immunology.
[117] M. Kabesch,et al. Genetic variations in toll‐like receptor pathway genes influence asthma and atopy , 2011, Allergy.
[118] J. Castro‐Rodriguez,et al. A clinical index to define risk of asthma in young children with recurrent wheezing. , 2000, American journal of respiratory and critical care medicine.
[119] B. Bender,et al. Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. , 2009, The Journal of pediatrics.
[120] P. Gergen,et al. Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents. , 2012, The Journal of allergy and clinical immunology.
[121] S T Holgate,et al. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. , 1990, The New England journal of medicine.
[122] J. Castro‐Rodriguez,et al. β-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: A systematic review with meta-analysis , 2004 .
[123] Ayne,et al. ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFE , 1995 .
[124] J. Vandenbroucke,et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.
[125] C. Sorkness,et al. Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. , 2011, The Journal of allergy and clinical immunology.
[126] C. Sorkness,et al. Development and cross-sectional validation of the Childhood Asthma Control Test. , 2007, The Journal of allergy and clinical immunology.
[127] A. Chang,et al. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. , 2008, The Cochrane database of systematic reviews.
[128] P. Kuna,et al. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. , 2008, The Journal of allergy and clinical immunology.
[129] H. Bisgaard,et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach , 2008, European Respiratory Journal.
[130] H. Donson,et al. Home-made spacers for bronchodilator therapy in children with acute asthma: a randomised trial , 1999, The Lancet.
[131] S. H. Arshad,et al. Effect of mite‐impermeable mattress encasings and an educational package on the development of allergies in a multinational randomized, controlled birth‐cohort study – 24 months results of the Study of Prevention of Allergy in Children in Europe , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[132] S. Szefler. Advancing asthma care: the glass is only half full! , 2011, The Journal of allergy and clinical immunology.
[133] Vernon M Chinchilli,et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. , 2006, The New England journal of medicine.
[134] O. Kalayci,et al. The effect of CD14 C159T polymorphism on in vitro IgE synthesis and cytokine production by PBMC from children with asthma , 2011, Allergy.
[135] G. Liss,et al. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. , 2004, The Journal of allergy and clinical immunology.
[136] G. Wennergren,et al. Asthma in late adolescence – farm childhood is protective and the prevalence increase has levelled off , 2010, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[137] T. Casale,et al. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. , 2012, The Journal of allergy and clinical immunology.
[138] N. Papadopoulos,et al. Duration of postviral airway hyperresponsiveness in children with asthma: Effect of atopy , 2005, Journal of Allergy and Clinical Immunology.
[139] E. Valovirta,et al. Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT study , 2007, Allergy.
[140] G. O'Connor,et al. Results of a home-based environmental intervention among urban children with asthma. , 2004, The New England journal of medicine.
[141] S. Nishima,et al. Japanese guideline for childhood asthma. , 2011, Allergology international : official journal of the Japanese Society of Allergology.
[142] D. Price,et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. , 2011, The New England journal of medicine.
[143] A. Woodcock,et al. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study , 2006, The Lancet.